Other techniques that have been exercised by researchers for MUC1 vaccines include liposome based cancer vaccines, targeting CD8+ T cells to stimulate CTL activity, dendritic cell vaccines loaded with peptide, and dendritic cell vaccines loaded with mRNA or transfected with cDNA [44]. This evidence concerns the gene MUC1 and cancer.